SMTL ID : 5zma.3 (2 other biounits)

Structural basis for an allosteric Eya2 phosphatase inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.17 Å

Oligo State

monomer

Ligands

1 x 9FX: 3-fluoro-N'-[(E)-{5-[(pyrimidin-2-yl)sulfanyl]furan-2-yl}methylidene]benzohydrazide(Non-covalent)

9FX.1: 15 residues within 4Å: Chain A: T.34, I.35, F.38, F.46, Y.50, M.64, R.170, L.173, L.176, T.177, D.178, W.180, L.181, Y.217, H.279 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:T.34, A:F.38, A:F.46, A:Y.50, A:L.173, A:L.181 Hydrogen bonds: A:T.34, A:W.180, A:L.181 pi-Stacking: A:Y.217

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Anantharajan, J. et al., Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells. Mol.Cancer Ther. (2019)

Release Date

2019-06-05

Peptides

Eyes absent homolog 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Eyes absent homolog 2

Related Entries With Identical Sequence